Overview

Intravenous Iron in Patients With Anemia of Chronic Kidney Disease

Status:
Unknown status
Trial end date:
2005-03-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anemic patients with chronic kidney disease not on renal replacement therapy.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital Muenster
Treatments:
Ferric Oxide, Saccharated
Iron
Criteria
Inclusion Criteria:

Chronic kidney disease Anemia (Hb 8 - 11.5 g/dl) Age above 18 years Signed informed consent

Exclusion Criteria:

Rapid progression of kidney disease Need for dialysis Uncontrolled hypertension